The University of Chicago Header Logo

Connection

Ardaman Shergill to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications Ardaman Shergill has written about Antineoplastic Agents.
Ardaman Shergill
Connection Strength
0.182
Antineoplastic Agents
  1. Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. N Engl J Med. 2025 Feb 13; 392(7):653-665.
    View in: PubMed
    Score: 0.100
  2. DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer. Anticancer Res. 2021 Nov; 41(11):5393-5403.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.